Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its ...

As people with a learning disability grow older, they experience a steep decline in available services and opportunities.

All the latest breaking UK news with in-depth comment and analysis, pictures and videos ...